SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CYTO
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
8116 49 0 CYTO
Emcee:  Mister E Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
8091Cytogen Can't Rule Out 'Material Expenditure' From Suit DOW JONES NEJim Oravetz-4/14/2004
8090Cytogen Publishes Novel Method for Identifying Protein Interactions in ProteomicJim Oravetz-3/5/2004
8089Cytogen Reports Record Product Revenues in the Fourth Quarter of 2003 and ProvidJim Oravetz-3/5/2004
8088Matritech Reports 3Q Fincl Results; Bladder Cancer Test Sales Up 87 % Over 2002 Jim Oravetz-11/5/2003
8087FYI: nature.com (EOM)Jim Oravetz-10/10/2003
80861: Bioorg Med Chem. 2003 Oct;11(20):4455-61. Related Articles, Links ConformatJim Oravetz-9/18/2003
8085New York Daily News NMP22 Article New York Daily News - nydailynews.com Quiet bJim Oravetz-9/18/2003
8084Cytogen Reacquires Marketing Rights To QUADRAMET(R) Pain Therapy Pdt DOW JONES NJim Oravetz-8/1/2003
808310:48 Volume Alert - Cytogen Corp spikes intraday amid a surge in volume (CYTO) Jim Oravetz-7/10/2003
8082GE Medical Systems And Cytogen Announce Marketing Alliance DOW JONES NEWSWIRES Jim Oravetz-6/24/2003
8081New Approach Could Reduce Number of Prostate Surgeries Imaging Technique Lets DoJim Oravetz-6/19/2003
8080Advanced Magnetics Up 5%; Co. Featured In Medical Journal DOW JONES NEWSWIRES BJim Oravetz-6/18/2003
8079Dr. Howard Scher, Memorial Sloan-Kettering Cancer Center, discussed and updated Jim Oravetz-6/18/2003
8078Cytogen Announces Pact To Reacquire Marketing Rights To QUADRAMET(R) Pain TherapJim Oravetz-6/16/2003
8077CYTO needs to expend all of its energy to promote NMP22. It has no other truly pdarbyred-6/5/2003
8076Cytogen Up 28% On Study Results Of Cancer Drug DOW JONES NEWSWIRES By Frank ByrtJim Oravetz-6/5/2003
8075Not sure if you follow biotech too much be almost all stocks that presented at tJim Oravetz-6/5/2003
8074CYTO finished after hours at 7.51 bid after closing at 5.16 Apparantly relatedArea51-6/4/2003
8073OLD News: IMAGING TOOL HELPS LOCATE SITES OF EARLY RECURRENT PROSTATE CANCER dukJim Oravetz-5/6/2003
8072Cytogen Gets Summary Judgment Of Non-Infringement DOW JONES NEWSWIRES PRINCETONJim Oravetz-5/1/2003
8071Cytogen And DRAXIMAGE Agree To Terminate BrachySeed Agreements DOW JONES NEWSWIRJim Oravetz-4/9/2003
8070Cytogen Reports Fourth Quarter and Full Year Results for 2002 PRINCETON, N.J., Jim Oravetz-3/12/2003
8069FYI:MLN591 is a monoclonal antibody to prostate specific membrane antigen (PSMA)Jim Oravetz-1/30/2003
8068CytRx Enters Strategic Alliance For Prostate Cancer DOW JONES NEWSWIRES LOS ANGJim Oravetz-1/27/2003
8067Cytogen Corporation to Regain Rights to Ex Vivo Prostate Cancer Immunotherapy Jim Oravetz-12/27/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News